COSCIENS Biopharma Inc. Reports Fourth Quarter and Full Year 2024 Financial Results and Provides a Corporate Update
Fully repositioned as a pure-play natural-based product company following strategic review and…
Fully repositioned as a pure-play natural-based product company following strategic review and…
Sign in to your account